233 related articles for article (PubMed ID: 23028593)
21. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
22. Role of orexin receptors in the ventral tegmental area on acquisition and expression of morphine-induced conditioned place preference in the rats.
Farahimanesh S; Zarrabian S; Haghparast A
Neuropeptides; 2017 Dec; 66():45-51. PubMed ID: 28890208
[TBL] [Abstract][Full Text] [Related]
23. The Role of Orexin Signaling in the Ventral Tegmental Area and Central Amygdala in Modulating Binge-Like Ethanol Drinking Behavior.
Olney JJ; Navarro M; Thiele TE
Alcohol Clin Exp Res; 2017 Mar; 41(3):551-561. PubMed ID: 28097729
[TBL] [Abstract][Full Text] [Related]
24. The orexin receptors in the ventral tegmental area are involved in the development of sensitization to expression of morphine-induced preference in rats.
Mahmoudi D; Assar N; Mousavi Z; Katebi SN; Azizi P; Haghparast A
Behav Pharmacol; 2020 Dec; 31(8):759-767. PubMed ID: 32925229
[TBL] [Abstract][Full Text] [Related]
25. Involvement of orexin-2 receptors in the ventral tegmental area and nucleus accumbens in the antinociception induced by the lateral hypothalamus stimulation in rats.
Azhdari-Zarmehri H; Reisi Z; Vaziri A; Haghparast A; Shaigani P; Haghparast A
Peptides; 2013 Sep; 47():94-8. PubMed ID: 23891649
[TBL] [Abstract][Full Text] [Related]
26. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine.
Zarepour L; Fatahi Z; Sarihi A; Haghparast A
Neuropeptides; 2014 Jun; 48(3):179-85. PubMed ID: 24793540
[TBL] [Abstract][Full Text] [Related]
27. Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant.
Hoever P; de Haas S; Winkler J; Schoemaker RC; Chiossi E; van Gerven J; Dingemanse J
Clin Pharmacol Ther; 2010 May; 87(5):593-600. PubMed ID: 20376002
[TBL] [Abstract][Full Text] [Related]
28. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.
Cason AM; Smith RJ; Tahsili-Fahadan P; Moorman DE; Sartor GC; Aston-Jones G
Physiol Behav; 2010 Jul; 100(5):419-28. PubMed ID: 20338186
[TBL] [Abstract][Full Text] [Related]
29. Tolerability, pharmacokinetics, and pharmacodynamics of single-dose almorexant, an orexin receptor antagonist, in healthy elderly subjects.
Hoever P; Hay J; Rad M; Cavallaro M; van Gerven JM; Dingemanse J
J Clin Psychopharmacol; 2013 Jun; 33(3):363-70. PubMed ID: 23609389
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the orexin/hypocretin system in ethanol conditioned place preference.
Voorhees CM; Cunningham CL
Psychopharmacology (Berl); 2011 Apr; 214(4):805-18. PubMed ID: 21107540
[TBL] [Abstract][Full Text] [Related]
31. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
[TBL] [Abstract][Full Text] [Related]
32. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.
Mahler SV; Smith RJ; Aston-Jones G
Psychopharmacology (Berl); 2013 Apr; 226(4):687-98. PubMed ID: 22411428
[TBL] [Abstract][Full Text] [Related]
33. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement.
Shoblock JR; Welty N; Aluisio L; Fraser I; Motley ST; Morton K; Palmer J; Bonaventure P; Carruthers NI; Lovenberg TW; Boggs J; Galici R
Psychopharmacology (Berl); 2011 May; 215(1):191-203. PubMed ID: 21181123
[TBL] [Abstract][Full Text] [Related]
34. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system.
España RA; Oleson EB; Locke JL; Brookshire BR; Roberts DC; Jones SR
Eur J Neurosci; 2010 Jan; 31(2):336-48. PubMed ID: 20039943
[TBL] [Abstract][Full Text] [Related]
35. Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats.
Brown RM; Kim AK; Khoo SY; Kim JH; Jupp B; Lawrence AJ
Addict Biol; 2016 May; 21(3):603-12. PubMed ID: 25899624
[TBL] [Abstract][Full Text] [Related]
36. Microinjection of glycine into the ventral tegmental area selectively decreases ethanol consumption.
Li J; Nie H; Bian W; Dave V; Janak PH; Ye JH
J Pharmacol Exp Ther; 2012 Apr; 341(1):196-204. PubMed ID: 22238211
[TBL] [Abstract][Full Text] [Related]
37. Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone.
Morairty SR; Revel FG; Malherbe P; Moreau JL; Valladao D; Wettstein JG; Kilduff TS; Borroni E
PLoS One; 2012; 7(7):e39131. PubMed ID: 22768296
[TBL] [Abstract][Full Text] [Related]
38. Role of orexin/hypocretin in conditioned sucrose-seeking in rats.
Cason AM; Aston-Jones G
Psychopharmacology (Berl); 2013 Mar; 226(1):155-65. PubMed ID: 23096770
[TBL] [Abstract][Full Text] [Related]
39. Orexin receptor antagonism: an ascending multiple-dose study with almorexant.
Hoever P; de Haas SL; Dorffner G; Chiossi E; van Gerven JM; Dingemanse J
J Psychopharmacol; 2012 Aug; 26(8):1071-80. PubMed ID: 22695489
[TBL] [Abstract][Full Text] [Related]
40. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation.
Beuckmann CT; Ueno T; Nakagawa M; Suzuki M; Akasofu S
Sleep; 2019 Jun; 42(6):. PubMed ID: 30923834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
